Ocular Complications in Survivors of the Ebola Outbreak in Guinea.
Identifieur interne : 001037 ( PubMed/Corpus ); précédent : 001036; suivant : 001038Ocular Complications in Survivors of the Ebola Outbreak in Guinea.
Auteurs : Esther Hereth-Hebert ; Mamadou Oury Bah ; Jean François Etard ; Mamadou Saliou Sow ; Serge Resnikoff ; Christine Fardeau ; Abdoulaye Toure ; Alexis Niouma Ouendeno ; Isaac Ceougna Sagno ; Laura March ; Suzanne Izard ; Pierre Louis Lama ; Moumié Barry ; Eric DelaporteSource :
- American journal of ophthalmology [ 1879-1891 ] ; 2017.
English descriptors
- KwdEn :
- Adolescent, Adult, Child, Child, Preschool, DNA, Viral (analysis), Diagnostic Techniques, Ophthalmological, Disease Outbreaks, Ebolavirus (genetics), Eye Infections, Viral (diagnosis), Eye Infections, Viral (epidemiology), Eye Infections, Viral (etiology), Female, Follow-Up Studies, Guinea (epidemiology), Hemorrhagic Fever, Ebola (complications), Hemorrhagic Fever, Ebola (epidemiology), Humans, Incidence, Keratitis (diagnosis), Keratitis (epidemiology), Keratitis (etiology), Male, Middle Aged, Prospective Studies, Scleritis (diagnosis), Scleritis (epidemiology), Scleritis (etiology), Survivors, Uveitis (diagnosis), Uveitis (epidemiology), Uveitis (etiology), Young Adult.
- MESH :
- chemical , analysis : DNA, Viral.
- complications : Hemorrhagic Fever, Ebola.
- diagnosis : Eye Infections, Viral, Keratitis, Scleritis, Uveitis.
- epidemiology : Eye Infections, Viral, Guinea, Hemorrhagic Fever, Ebola, Keratitis, Scleritis, Uveitis.
- etiology : Eye Infections, Viral, Keratitis, Scleritis, Uveitis.
- genetics : Ebolavirus.
- Adolescent, Adult, Child, Child, Preschool, Diagnostic Techniques, Ophthalmological, Disease Outbreaks, Female, Follow-Up Studies, Humans, Incidence, Male, Middle Aged, Prospective Studies, Survivors, Young Adult.
Abstract
The Ebola outbreak of 2013-2016 severely affected West Africa and resulted in 2544 deaths and 1270 survivors in Guinea, the country where it began. This Ebola virus was the Zaire strain of the virus family Filoviridae. In this outbreak the case fatality rate was about 67%. The survivors, declared cured after 2 negative blood polymerase chain reaction (PCR) results, face psychosocial disorders and rheumatic, ear-nose-throat, neurocognitive, and ophthalmologic complications. The goal of this study was to detect and describe ocular complications afflicting these survivors and to observe their occurrence and recurrences.
DOI: 10.1016/j.ajo.2016.12.005
PubMed: 27998698
Links to Exploration step
pubmed:27998698Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Ocular Complications in Survivors of the Ebola Outbreak in Guinea.</title><author><name sortKey="Hereth Hebert, Esther" sort="Hereth Hebert, Esther" uniqKey="Hereth Hebert E" first="Esther" last="Hereth-Hebert">Esther Hereth-Hebert</name><affiliation><nlm:affiliation>IRD UMI 233 INSERM U 1175, University of Montpellier, Montpellier, France. Electronic address: oph.ehereth@gmail.com.</nlm:affiliation></affiliation></author><author><name sortKey="Bah, Mamadou Oury" sort="Bah, Mamadou Oury" uniqKey="Bah M" first="Mamadou Oury" last="Bah">Mamadou Oury Bah</name><affiliation><nlm:affiliation>CADESSO - Centre d'Application du Diplôme d'Etudes Supérieures Spécialisées en Ophtalmologie, Conakry, Guinea.</nlm:affiliation></affiliation></author><author><name sortKey="Etard, Jean Francois" sort="Etard, Jean Francois" uniqKey="Etard J" first="Jean François" last="Etard">Jean François Etard</name><affiliation><nlm:affiliation>IRD UMI 233 INSERM U 1175, University of Montpellier, Montpellier, France.</nlm:affiliation></affiliation></author><author><name sortKey="Sow, Mamadou Saliou" sort="Sow, Mamadou Saliou" uniqKey="Sow M" first="Mamadou Saliou" last="Sow">Mamadou Saliou Sow</name><affiliation><nlm:affiliation>Infectious Disease Department, Donka University National Hospital, Conakry, Guinea.</nlm:affiliation></affiliation></author><author><name sortKey="Resnikoff, Serge" sort="Resnikoff, Serge" uniqKey="Resnikoff S" first="Serge" last="Resnikoff">Serge Resnikoff</name><affiliation><nlm:affiliation>Brien Holden Vision Institute, University of New South Wales, Sydney, Australia; Organisation Pour la prévention de la Cécité (OPC), Paris, France.</nlm:affiliation></affiliation></author><author><name sortKey="Fardeau, Christine" sort="Fardeau, Christine" uniqKey="Fardeau C" first="Christine" last="Fardeau">Christine Fardeau</name><affiliation><nlm:affiliation>Department of Ophthalmology, Pitié-Salpêtrière Hospital, APHP, Paris, France.</nlm:affiliation></affiliation></author><author><name sortKey="Toure, Abdoulaye" sort="Toure, Abdoulaye" uniqKey="Toure A" first="Abdoulaye" last="Toure">Abdoulaye Toure</name><affiliation><nlm:affiliation>IRD UMI 233 INSERM U 1175, University of Montpellier, Montpellier, France; Public Health and Department of Pharmacy, Conakry University, Conakry, Guinea.</nlm:affiliation></affiliation></author><author><name sortKey="Ouendeno, Alexis Niouma" sort="Ouendeno, Alexis Niouma" uniqKey="Ouendeno A" first="Alexis Niouma" last="Ouendeno">Alexis Niouma Ouendeno</name><affiliation><nlm:affiliation>CADESSO - Centre d'Application du Diplôme d'Etudes Supérieures Spécialisées en Ophtalmologie, Conakry, Guinea.</nlm:affiliation></affiliation></author><author><name sortKey="Sagno, Isaac Ceougna" sort="Sagno, Isaac Ceougna" uniqKey="Sagno I" first="Isaac Ceougna" last="Sagno">Isaac Ceougna Sagno</name><affiliation><nlm:affiliation>Department of Ophthalmology, Nzérékoré Regional Hospital, Nzérékoré, Guinea.</nlm:affiliation></affiliation></author><author><name sortKey="March, Laura" sort="March, Laura" uniqKey="March L" first="Laura" last="March">Laura March</name><affiliation><nlm:affiliation>IRD UMI 233 INSERM U 1175, University of Montpellier, Montpellier, France.</nlm:affiliation></affiliation></author><author><name sortKey="Izard, Suzanne" sort="Izard, Suzanne" uniqKey="Izard S" first="Suzanne" last="Izard">Suzanne Izard</name><affiliation><nlm:affiliation>IRD UMI 233 INSERM U 1175, University of Montpellier, Montpellier, France.</nlm:affiliation></affiliation></author><author><name sortKey="Lama, Pierre Louis" sort="Lama, Pierre Louis" uniqKey="Lama P" first="Pierre Louis" last="Lama">Pierre Louis Lama</name><affiliation><nlm:affiliation>CADESSO - Centre d'Application du Diplôme d'Etudes Supérieures Spécialisées en Ophtalmologie, Conakry, Guinea.</nlm:affiliation></affiliation></author><author><name sortKey="Barry, Moumie" sort="Barry, Moumie" uniqKey="Barry M" first="Moumié" last="Barry">Moumié Barry</name><affiliation><nlm:affiliation>Infectious Disease Department, Donka University National Hospital, Conakry, Guinea.</nlm:affiliation></affiliation></author><author><name sortKey="Delaporte, Eric" sort="Delaporte, Eric" uniqKey="Delaporte E" first="Eric" last="Delaporte">Eric Delaporte</name><affiliation><nlm:affiliation>IRD UMI 233 INSERM U 1175, University of Montpellier, Montpellier, France.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:27998698</idno><idno type="pmid">27998698</idno><idno type="doi">10.1016/j.ajo.2016.12.005</idno><idno type="wicri:Area/PubMed/Corpus">001037</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001037</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Ocular Complications in Survivors of the Ebola Outbreak in Guinea.</title><author><name sortKey="Hereth Hebert, Esther" sort="Hereth Hebert, Esther" uniqKey="Hereth Hebert E" first="Esther" last="Hereth-Hebert">Esther Hereth-Hebert</name><affiliation><nlm:affiliation>IRD UMI 233 INSERM U 1175, University of Montpellier, Montpellier, France. Electronic address: oph.ehereth@gmail.com.</nlm:affiliation></affiliation></author><author><name sortKey="Bah, Mamadou Oury" sort="Bah, Mamadou Oury" uniqKey="Bah M" first="Mamadou Oury" last="Bah">Mamadou Oury Bah</name><affiliation><nlm:affiliation>CADESSO - Centre d'Application du Diplôme d'Etudes Supérieures Spécialisées en Ophtalmologie, Conakry, Guinea.</nlm:affiliation></affiliation></author><author><name sortKey="Etard, Jean Francois" sort="Etard, Jean Francois" uniqKey="Etard J" first="Jean François" last="Etard">Jean François Etard</name><affiliation><nlm:affiliation>IRD UMI 233 INSERM U 1175, University of Montpellier, Montpellier, France.</nlm:affiliation></affiliation></author><author><name sortKey="Sow, Mamadou Saliou" sort="Sow, Mamadou Saliou" uniqKey="Sow M" first="Mamadou Saliou" last="Sow">Mamadou Saliou Sow</name><affiliation><nlm:affiliation>Infectious Disease Department, Donka University National Hospital, Conakry, Guinea.</nlm:affiliation></affiliation></author><author><name sortKey="Resnikoff, Serge" sort="Resnikoff, Serge" uniqKey="Resnikoff S" first="Serge" last="Resnikoff">Serge Resnikoff</name><affiliation><nlm:affiliation>Brien Holden Vision Institute, University of New South Wales, Sydney, Australia; Organisation Pour la prévention de la Cécité (OPC), Paris, France.</nlm:affiliation></affiliation></author><author><name sortKey="Fardeau, Christine" sort="Fardeau, Christine" uniqKey="Fardeau C" first="Christine" last="Fardeau">Christine Fardeau</name><affiliation><nlm:affiliation>Department of Ophthalmology, Pitié-Salpêtrière Hospital, APHP, Paris, France.</nlm:affiliation></affiliation></author><author><name sortKey="Toure, Abdoulaye" sort="Toure, Abdoulaye" uniqKey="Toure A" first="Abdoulaye" last="Toure">Abdoulaye Toure</name><affiliation><nlm:affiliation>IRD UMI 233 INSERM U 1175, University of Montpellier, Montpellier, France; Public Health and Department of Pharmacy, Conakry University, Conakry, Guinea.</nlm:affiliation></affiliation></author><author><name sortKey="Ouendeno, Alexis Niouma" sort="Ouendeno, Alexis Niouma" uniqKey="Ouendeno A" first="Alexis Niouma" last="Ouendeno">Alexis Niouma Ouendeno</name><affiliation><nlm:affiliation>CADESSO - Centre d'Application du Diplôme d'Etudes Supérieures Spécialisées en Ophtalmologie, Conakry, Guinea.</nlm:affiliation></affiliation></author><author><name sortKey="Sagno, Isaac Ceougna" sort="Sagno, Isaac Ceougna" uniqKey="Sagno I" first="Isaac Ceougna" last="Sagno">Isaac Ceougna Sagno</name><affiliation><nlm:affiliation>Department of Ophthalmology, Nzérékoré Regional Hospital, Nzérékoré, Guinea.</nlm:affiliation></affiliation></author><author><name sortKey="March, Laura" sort="March, Laura" uniqKey="March L" first="Laura" last="March">Laura March</name><affiliation><nlm:affiliation>IRD UMI 233 INSERM U 1175, University of Montpellier, Montpellier, France.</nlm:affiliation></affiliation></author><author><name sortKey="Izard, Suzanne" sort="Izard, Suzanne" uniqKey="Izard S" first="Suzanne" last="Izard">Suzanne Izard</name><affiliation><nlm:affiliation>IRD UMI 233 INSERM U 1175, University of Montpellier, Montpellier, France.</nlm:affiliation></affiliation></author><author><name sortKey="Lama, Pierre Louis" sort="Lama, Pierre Louis" uniqKey="Lama P" first="Pierre Louis" last="Lama">Pierre Louis Lama</name><affiliation><nlm:affiliation>CADESSO - Centre d'Application du Diplôme d'Etudes Supérieures Spécialisées en Ophtalmologie, Conakry, Guinea.</nlm:affiliation></affiliation></author><author><name sortKey="Barry, Moumie" sort="Barry, Moumie" uniqKey="Barry M" first="Moumié" last="Barry">Moumié Barry</name><affiliation><nlm:affiliation>Infectious Disease Department, Donka University National Hospital, Conakry, Guinea.</nlm:affiliation></affiliation></author><author><name sortKey="Delaporte, Eric" sort="Delaporte, Eric" uniqKey="Delaporte E" first="Eric" last="Delaporte">Eric Delaporte</name><affiliation><nlm:affiliation>IRD UMI 233 INSERM U 1175, University of Montpellier, Montpellier, France.</nlm:affiliation></affiliation></author></analytic><series><title level="j">American journal of ophthalmology</title><idno type="eISSN">1879-1891</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Child</term><term>Child, Preschool</term><term>DNA, Viral (analysis)</term><term>Diagnostic Techniques, Ophthalmological</term><term>Disease Outbreaks</term><term>Ebolavirus (genetics)</term><term>Eye Infections, Viral (diagnosis)</term><term>Eye Infections, Viral (epidemiology)</term><term>Eye Infections, Viral (etiology)</term><term>Female</term><term>Follow-Up Studies</term><term>Guinea (epidemiology)</term><term>Hemorrhagic Fever, Ebola (complications)</term><term>Hemorrhagic Fever, Ebola (epidemiology)</term><term>Humans</term><term>Incidence</term><term>Keratitis (diagnosis)</term><term>Keratitis (epidemiology)</term><term>Keratitis (etiology)</term><term>Male</term><term>Middle Aged</term><term>Prospective Studies</term><term>Scleritis (diagnosis)</term><term>Scleritis (epidemiology)</term><term>Scleritis (etiology)</term><term>Survivors</term><term>Uveitis (diagnosis)</term><term>Uveitis (epidemiology)</term><term>Uveitis (etiology)</term><term>Young Adult</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en"><term>DNA, Viral</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Hemorrhagic Fever, Ebola</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Eye Infections, Viral</term><term>Keratitis</term><term>Scleritis</term><term>Uveitis</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Eye Infections, Viral</term><term>Guinea</term><term>Hemorrhagic Fever, Ebola</term><term>Keratitis</term><term>Scleritis</term><term>Uveitis</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Eye Infections, Viral</term><term>Keratitis</term><term>Scleritis</term><term>Uveitis</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Ebolavirus</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Child</term><term>Child, Preschool</term><term>Diagnostic Techniques, Ophthalmological</term><term>Disease Outbreaks</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Incidence</term><term>Male</term><term>Middle Aged</term><term>Prospective Studies</term><term>Survivors</term><term>Young Adult</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The Ebola outbreak of 2013-2016 severely affected West Africa and resulted in 2544 deaths and 1270 survivors in Guinea, the country where it began. This Ebola virus was the Zaire strain of the virus family Filoviridae. In this outbreak the case fatality rate was about 67%. The survivors, declared cured after 2 negative blood polymerase chain reaction (PCR) results, face psychosocial disorders and rheumatic, ear-nose-throat, neurocognitive, and ophthalmologic complications. The goal of this study was to detect and describe ocular complications afflicting these survivors and to observe their occurrence and recurrences.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27998698</PMID><DateCreated><Year>2016</Year><Month>12</Month><Day>21</Day></DateCreated><DateCompleted><Year>2017</Year><Month>05</Month><Day>04</Day></DateCompleted><DateRevised><Year>2017</Year><Month>07</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-1891</ISSN><JournalIssue CitedMedium="Internet"><Volume>175</Volume><PubDate><Year>2017</Year><Month>Mar</Month></PubDate></JournalIssue><Title>American journal of ophthalmology</Title><ISOAbbreviation>Am. J. Ophthalmol.</ISOAbbreviation></Journal><ArticleTitle>Ocular Complications in Survivors of the Ebola Outbreak in Guinea.</ArticleTitle><Pagination><MedlinePgn>114-121</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0002-9394(16)30602-X</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajo.2016.12.005</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The Ebola outbreak of 2013-2016 severely affected West Africa and resulted in 2544 deaths and 1270 survivors in Guinea, the country where it began. This Ebola virus was the Zaire strain of the virus family Filoviridae. In this outbreak the case fatality rate was about 67%. The survivors, declared cured after 2 negative blood polymerase chain reaction (PCR) results, face psychosocial disorders and rheumatic, ear-nose-throat, neurocognitive, and ophthalmologic complications. The goal of this study was to detect and describe ocular complications afflicting these survivors and to observe their occurrence and recurrences.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Prospective observational cohort study.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This prospective observational multicenter cohort study was initiated in March 2015. The cohort study included 341 survivors followed up in the infectious disease ward of Conakry, Forecariah, and Nzérékoré as of May 2016. The patients received multidisciplinary medical follow-up expected to last at least 1 year that included an eye examination as part of complete, free treatment.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Systematic examination of 341 patients revealed 46 cases of uveitis (13.5%), 6 cases of episcleritis (1.8%), and 3 cases of interstitial keratitis (0.9%). Uveitis was most frequently unilateral (78.3%) and anterior (47.8%) and occurred within the 2 months after discharge from the Ebola treatment center. Moreover, uveitis relapses were found up to 13 months after the negative PCR result for Ebola in the blood.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Nearly 1 out of 6 survivors presented ocular disorders after discharge from the Ebola treatment center. An ophthalmologic follow-up for Ebola-infected patients should start, if possible, during the acute phase of the disease and last more than 1 year. Treatment guidelines need to be urgently developed and implemented.</AbstractText><CopyrightInformation>Copyright © 2016 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hereth-Hebert</LastName><ForeName>Esther</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>IRD UMI 233 INSERM U 1175, University of Montpellier, Montpellier, France. Electronic address: oph.ehereth@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bah</LastName><ForeName>Mamadou Oury</ForeName><Initials>MO</Initials><AffiliationInfo><Affiliation>CADESSO - Centre d'Application du Diplôme d'Etudes Supérieures Spécialisées en Ophtalmologie, Conakry, Guinea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Etard</LastName><ForeName>Jean François</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>IRD UMI 233 INSERM U 1175, University of Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sow</LastName><ForeName>Mamadou Saliou</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Infectious Disease Department, Donka University National Hospital, Conakry, Guinea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Resnikoff</LastName><ForeName>Serge</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Brien Holden Vision Institute, University of New South Wales, Sydney, Australia; Organisation Pour la prévention de la Cécité (OPC), Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fardeau</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Pitié-Salpêtrière Hospital, APHP, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toure</LastName><ForeName>Abdoulaye</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>IRD UMI 233 INSERM U 1175, University of Montpellier, Montpellier, France; Public Health and Department of Pharmacy, Conakry University, Conakry, Guinea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ouendeno</LastName><ForeName>Alexis Niouma</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>CADESSO - Centre d'Application du Diplôme d'Etudes Supérieures Spécialisées en Ophtalmologie, Conakry, Guinea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sagno</LastName><ForeName>Isaac Ceougna</ForeName><Initials>IC</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Nzérékoré Regional Hospital, Nzérékoré, Guinea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>March</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>IRD UMI 233 INSERM U 1175, University of Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Izard</LastName><ForeName>Suzanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>IRD UMI 233 INSERM U 1175, University of Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lama</LastName><ForeName>Pierre Louis</ForeName><Initials>PL</Initials><AffiliationInfo><Affiliation>CADESSO - Centre d'Application du Diplôme d'Etudes Supérieures Spécialisées en Ophtalmologie, Conakry, Guinea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barry</LastName><ForeName>Moumié</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Infectious Disease Department, Donka University National Hospital, Conakry, Guinea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delaporte</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>IRD UMI 233 INSERM U 1175, University of Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Postebogui Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>12</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Ophthalmol</MedlineTA><NlmUniqueID>0370500</NlmUniqueID><ISSNLinking>0002-9394</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004279">DNA, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004279" MajorTopicYN="N">DNA, Viral</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003941" MajorTopicYN="N">Diagnostic Techniques, Ophthalmological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="Y">Disease Outbreaks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029043" MajorTopicYN="N">Ebolavirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015828" MajorTopicYN="N">Eye Infections, Viral</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016701" MajorTopicYN="N">Guinea</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019142" MajorTopicYN="N">Hemorrhagic Fever, Ebola</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007634" MajorTopicYN="N">Keratitis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015423" MajorTopicYN="N">Scleritis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017741" MajorTopicYN="N">Survivors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014605" MajorTopicYN="N">Uveitis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><InvestigatorList><Investigator ValidYN="Y"><LastName>Ayouba</LastName><ForeName>Ahidjo</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baize</LastName><ForeName>Sylvain</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Barry</LastName><ForeName>Moumié</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Camara</LastName><ForeName>Amadou</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cissé</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Delaporte</LastName><ForeName>Eric</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Delfraissy</LastName><ForeName>Jean-François</ForeName><Initials>JF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Delmas</LastName><ForeName>Christelle</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Desclaux</LastName><ForeName>Alice</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Diallo</LastName><ForeName>Saliou Bella</ForeName><Initials>SB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Diallo</LastName><ForeName>Mariama Sadio</ForeName><Initials>MS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Étard</LastName><ForeName>Jean François</ForeName><Initials>JF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Etienne</LastName><ForeName>Cécile</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Granouillac</LastName><ForeName>Bruno</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Izard</LastName><ForeName>Suzanne</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kassé</LastName><ForeName>Djenaba</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Keita</LastName><ForeName>Alpha Kabinet</ForeName><Initials>AK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Keita</LastName><ForeName>Sakoba</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hébert</LastName><ForeName>Esther Hereth</ForeName><Initials>EH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Koivugui</LastName><ForeName>Lamine</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kpamou</LastName><ForeName>Cece</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lacarabaratz</LastName><ForeName>Christine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leroy</LastName><ForeName>Sandrine</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marchal</LastName><ForeName>Claire Levy</ForeName><Initials>CL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Levy</LastName><ForeName>Yves</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Magassouba</LastName><ForeName>N'Fally</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>March</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Peeters</LastName><ForeName>Martine</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Raoul</LastName><ForeName>Hervé</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Savané</LastName><ForeName>Ibrahima</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sow</LastName><ForeName>Mamadou Saliou</ForeName><Initials>MS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Taverne</LastName><ForeName>Bernard</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Touré</LastName><ForeName>Abdoulaye</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yazdanpanah</LastName><ForeName>Yazdan</ForeName><Initials>Y</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>06</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>12</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>12</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>5</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27998698</ArticleId><ArticleId IdType="pii">S0002-9394(16)30602-X</ArticleId><ArticleId IdType="doi">10.1016/j.ajo.2016.12.005</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001037 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001037 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:27998698
|texte= Ocular Complications in Survivors of the Ebola Outbreak in Guinea.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:27998698" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |